Johnson and Johnson Completes Acquisition of Shockwave Medical
DAIC
MAY 31, 2024
Joaquin Duato , Chairman and Chief Executive Officer of Johnson & Johnson, said, “Through Innovative Medicine and MedTech, Johnson & Johnson is transforming the trajectory of cardiovascular disease, one of the leading causes of death globally. in 2024 and approximately $0.17
Let's personalize your content